Quercetin: Why It's in Your HOP Box
A Natural Senolytic That Helps Your Body Clear Damaged Cells
As you age, your body accumulates senescent cells, sometimes called "zombie cells." These are old, damaged cells that refuse to die and instead release inflammatory signals that accelerate aging in surrounding tissues. This process drives wrinkles, joint stiffness, fatigue, and chronic disease.
Quercetin is a flavonoid found in onions, apples, and berries that has emerged as one of the most studied natural senolytic compounds. Senolytics are substances that selectively clear senescent cells, giving your body a chance to regenerate with healthier tissue.
In HOP Box, quercetin is part of the Damage Control blend, working alongside fisetin, apigenin, curcumin, and astaxanthin to target multiple pathways of cellular aging.
What the Research Shows
Senolytic activity in humans
The combination of quercetin with dasatinib became the first senolytic therapy tested in humans, pioneered by researchers at Mayo Clinic. This landmark work proved that clearing senescent cells in humans is possible and measurable.
Key study: The first-in-human pilot trial of senolytic drugs showed that dasatinib plus quercetin decreased senescent cell burden in patients with diabetic kidney disease, reducing adipose tissue senescent cell markers and circulating inflammatory factors after just 3 days of treatment.
Hickson LJ, Langhi Prata LGP, Boez SA, et al. "Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease." EBioMedicine. 2019;47:446-456.
Inflammation and cardiovascular markers
Chronic low-grade inflammation ("inflammaging") is a hallmark of aging. Quercetin has demonstrated anti-inflammatory effects in multiple human trials.
Key study: A meta-analysis of 9 randomized controlled trials found that quercetin supplementation significantly reduced C-reactive protein (CRP), a key inflammatory marker, particularly at doses of 500 mg/day or higher and in studies lasting 8 weeks or more.
Mohammadi-Sartang M, Mazloom Z, Sherafatmanesh S, et al. "Effects of supplementation with quercetin on plasma C-reactive protein concentrations: a systematic review and meta-analysis of randomized controlled trials." European Journal of Clinical Nutrition. 2017;71(9):1033-1039.
Blood pressure
Hypertension risk increases significantly for women after menopause. Quercetin has shown meaningful effects on blood pressure in multiple trials.
Key study: A meta-analysis of 7 randomized controlled trials (587 participants) found that quercetin supplementation significantly reduced both systolic and diastolic blood pressure, with the strongest effects seen at doses of 500 mg/day or more.
Serban MC, Sahebkar A, Zanchetti A, et al. "Effects of Quercetin on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials." Journal of the American Heart Association. 2016;5(7):e002713.
Bone formation in postmenopausal women
One of the most exciting recent studies shows quercetin's senolytic effects directly benefit bone health in aging women.
Key study: A Phase 2 randomized controlled trial in 60 postmenopausal women found that intermittent dasatinib plus quercetin (3 days every 28 days for 20 weeks) increased the bone formation marker P1NP by 16%. Women with the highest senescent cell burden showed the most benefit, with increased bone formation and reduced bone resorption. Published in Nature Medicine.
Farr JN, Atkinson EJ, Achenbach SJ, et al. "Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial." Nature Medicine. 2024;30(9):2605-2612.
Physical function in older adults
Quercetin combined with dasatinib has been tested specifically for improving physical function in aging populations.
Key study: In a pilot study of patients with idiopathic pulmonary fibrosis (a disease of accelerated aging), intermittent dasatinib plus quercetin for 3 weeks improved physical function as measured by 6-minute walk distance, walking speed, and chair-stand performance.
Justice JN, Nambiar AM, Tchkonia T, et al. "Senolytics in idiopathic pulmonary fibrosis: results from a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial." EBioMedicine. 2019;40:554-563.
Why It's in HOP Box
Dr. Amy Killen included quercetin in HOP Box because senescent cell accumulation is one of the fundamental drivers of aging. While the Mayo Clinic trials used quercetin alongside a prescription drug (dasatinib), quercetin on its own has demonstrated anti-inflammatory, cardiovascular, and antioxidant benefits that support healthy aging at any dose.
In the Damage Control blend, quercetin works synergistically with fisetin (another potent senolytic) to target zombie cells from multiple angles.
The HOP Box Difference
- Combined with fisetin for enhanced senolytic activity
- Part of the Damage Control blend with 4 other cell-protective ingredients
- Doctor-formulated by Amy Killen, MD, a longevity medicine specialist
- Convenient daily packs designed for consistent, long-term use
Ready to help your body clear damaged cells and age more slowly?
This page is for educational purposes only and is not medical advice. Always consult your healthcare provider before starting any supplement regimen.
Sources cited are peer-reviewed human clinical studies. HOP Box is formulated by Amy Killen, MD.
